Company Name: Oxygen Therapy Inc.

Founded: 2010

Headquarters: San Francisco, California 

Industry: Healthcare/Medical Devices

Company Overview:

Oxygen Therapy Inc. is a pioneering medical technology company focused on developing innovative oxygen delivery systems and respiratory therapy solutions. Our mission is to improve the quality of life for patients suffering from chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), emphysema, and severe asthma.

Our flagship product is the OxyFlow® Portable Oxygen Concentrator, a lightweight and user-friendly device that provides supplemental oxygen to patients on the go. Unlike traditional oxygen tanks, the OxyFlow uses advanced filtration technology to extract oxygen from the surrounding air, offering a more convenient and cost-effective solution for oxygen therapy.

In addition to the OxyFlow, we offer a range of respiratory therapy products, including high-flow nasal cannulas, nebulizers, and CPAP/BiPAP machines for sleep apnea management.

Key Milestones:

- 2010: Company founded by biomedical engineers and respiratory therapists

- 2013: OxyFlow Portable Oxygen Concentrator launched after successful clinical trials

- 2016: Expanded product line with the introduction of high-flow nasal cannula systems

- 2019: Received FDA clearance for our next-generation OxyFlow Pro model

- 2022: Opened new state-of-the-art manufacturing facility in San Francisco

Management team:

- CEO: Dr. Emily Wilson (PhD in Biomedical Engineering)

- CTO: Dr. Michael Chen (PhD in Respiratory Therapy)

- CFO: John Davis (MBA, Former VP of Finance at MedTech Corp.)

Oxygen Therapy Inc. is committed to research and development, constantly striving to improve our products and introduce new innovations to the respiratory care market. With a team of experienced engineers, medical professionals, and industry experts, we aim to be the leading provider of advanced oxygen therapy solutions worldwide.